- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02019108
Gait Modification Treatment for Knee Osteoarthritis
April 15, 2019 updated by: Michael Hunt, University of British Columbia
Effects of Toe-out Gait Modification on Clinical and Biomechanical Measures in People With Knee Osteoarthritis
Knee osteoarthritis (OA) is a costly health condition affecting more than 10% of Canadian adults.
Excessive and unbalanced loads passing through the knee joint have been implicated in the progression of OA.
Typical conservative treatment of OA has focused on increasing daily activity, without consideration for the underlying joint loading.
This study aims to compare a 4-month walking program that aims to increase the angle of the foot (toe-out angle) during walking - a measure shown to reduce joint loading and OA disease progression - while increasing walking time/distance, with a standard walking program that aims to increase walking time/distance.
It is predicted that the walking program focusing on increasing toe-out will provide greater reductions in self-reported knee pain and a greater reduction in unfavorable knee joint loading.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
79
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6T 1Z3
- Motion Analysis and Biofeedback Laboratory, The University of British Columbia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- aged 50 years and older
- radiographically confirmed medial compartment tibia-femoral knee osteoarthritis
- available for weekly training sessions in the Vancouver British Columbia Canada region
- able to safely perform treadmill walking under therapist supervision
Exclusion Criteria:
- articular cartilage degradation in the lateral tibiofemoral compartment greater than the medial
- inflammatory arthritic condition
- history of knee replacement or arthroscopic knee surgery
- recent use of corticosteroids (oral or via injection)
- inability to ambulate without a gait aid
- non-English speaking
- planning to commence a new treatment approach within the next 4 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gait Modification Group
Participants will complete 4 months of a home-based progressive walking program with toe-out gait modification aimed at improving physical activity level.
This group will perform continuous treadmill walking during regular sessions with a study therapist and will be instructed to perform a toe-out gait, with the aid of a mirror during walking.
Focus will also be on increasing the time and distance of walking.
These goals will be emphasized for the home-based portion of the intervention as well.
|
Participants in this study group will perform continuous treadmill walking for a minimum of 30 minutes at each session, but the emphasis will be to increase toe-out angle by 10 degrees over that exhibited at baseline.
A mirror will be provided for biofeedback and participants will be instructed on its use for achieving the target toe-out angle.
Increased walking time and distance will be encouraged the same as for the control group.
|
|
Active Comparator: Walking Only Group
Participants will complete 4 months of a home-based progressive walking program aimed at improving physical activity level.
This group will perform continuous treadmill walking during regular sessions with the study therapist with focus on increasing the time and distance of walking.
This goal will be emphasized for the home-based portion of the intervention as well.
|
At each scheduled visit, participants will perform treadmill walking for a minimum of 30 minutes depending on the individual's baseline activity level and the stage of the intervention.
Emphasis will be solely on increasing walking time and distance to achieve the target of a 40% increase in daily activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Pain as Measured by Numerical Rating Scale
Time Frame: Weeks 0, 17, 21
|
Average pain over the previous week will be assessed using an 11-point numerical rating scale (0 = no pain; 10 = maximum pain).
Higher scores mean a worse outcome.
Change was calculated as the value at 17 weeks and at 21 weeks minus the value at baseline.
|
Weeks 0, 17, 21
|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale.
Time Frame: Weeks 0, 17, 21
|
Lower-limb impairments will be measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
The WOMAC is a 24-item self-report questionnaire that quantifies pain (5 items), stiffness (2 items), and physical function (17 items).
It is a valid, reliable, and responsive disease-specific self-report instrument and has been used in many knee OA studies.
Minimum value of the WOMAC pain subscale is 0 and maximum value is 20.
Higher scores mean a worse outcome.
|
Weeks 0, 17, 21
|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Knee Joint Loading: First Peak Knee Adduction Moment
Time Frame: Weeks 0, 17, 21
|
Participants will undergo a gait analysis, where 10-15 trials of walking will be collected.
Participants will walk in bare feet and at their own, self-selected speed while analyzed using three-dimensional motion analysis.
Kinematic (joint angle) and kinetic (joint loading) data will be collected synchronously using high-speed digital cameras and floor-mounted force platforms.
A total of 5 "acceptable" (clean force platform strikes and no observable deviation in walking characteristics) will be analyzed.
|
Weeks 0, 17, 21
|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Knee Joint Loading: Second Peak Knee Adduction Moment
Time Frame: Weeks 0, 17, 21
|
Participants will undergo a gait analysis, where 10-15 trials of walking will be collected.
Participants will walk in bare feet and at their own, self-selected speed while analyzed using three-dimensional motion analysis.
Kinematic (joint angle) and kinetic (joint loading) data will be collected synchronously using high-speed digital cameras and floor-mounted force platforms.
A total of 5 "acceptable" (clean force platform strikes and no observable deviation in walking characteristics) will be analyzed.
|
Weeks 0, 17, 21
|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Knee Joint Loading: Knee Adduction Moment Impulse
Time Frame: Weeks 0, 17, 21
|
Participants will undergo a gait analysis, where 10-15 trials of walking will be collected.
Participants will walk in bare feet and at their own, self-selected speed while analyzed using three-dimensional motion analysis.
Kinematic (joint angle) and kinetic (joint loading) data will be collected synchronously using high-speed digital cameras and floor-mounted force platforms.
A total of 5 "acceptable" (clean force platform strikes and no observable deviation in walking characteristics) will be analyzed.
|
Weeks 0, 17, 21
|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Foot Progression Angle (FPA)
Time Frame: Weeks 0, 17, 21
|
FPA indicates orientation of the foot with respect to the forward progression of the body.
Positive values correspond to a toe-in orientation, whereas negative values correspond to a toe-out orientation.
Therefore, a positive change value indicates more toe-in versus a negative change value indicates more toe-out.
|
Weeks 0, 17, 21
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Self-reported Physical Function as Measured by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function Subscale.
Time Frame: Weeks 0, 17, 21
|
Lower-limb impairments will be measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
The WOMAC is a 24-item self-report questionnaire that quantifies pain (5 items), stiffness (2 items), and physical function (17 items).
It is a valid, reliable, and responsive disease-specific self-report instrument and has been used in many knee OA studies.
The WOMAC physical function subscale minimum value is 0 and maximum value is 68.
Higher scores mean a worse outcome.
|
Weeks 0, 17, 21
|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Objective Physical Function as Measured by Timed Stair Climb.
Time Frame: Weeks 0, 17, 21
|
Participants were instructed to ascend 12 stairs "as quickly as possible", and the fastest time from two attempts was recorded.
|
Weeks 0, 17, 21
|
|
Change From Baseline to Week 17 and From Baseline to Week 21 in Knee Joint Loading: Knee Flexion Moment
Time Frame: Weeks 0, 17, 21
|
Participants will undergo a gait analysis, where 10-15 trials of walking will be collected.
Participants will walk in bare feet and at their own, self-selected speed while analyzed using three-dimensional motion analysis.
Kinematic (joint angle) and kinetic (joint loading) data will be collected synchronously using high-speed digital cameras and floor-mounted force platforms.
A total of 5 "acceptable" (clean force platform strikes and no observable deviation in walking characteristics) will be analyzed.
|
Weeks 0, 17, 21
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael A Hunt, PT, PhD, The University of British Columbia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2014
Primary Completion (Actual)
October 1, 2017
Study Completion (Actual)
October 1, 2017
Study Registration Dates
First Submitted
December 5, 2013
First Submitted That Met QC Criteria
December 17, 2013
First Posted (Estimate)
December 24, 2013
Study Record Updates
Last Update Posted (Actual)
July 5, 2019
Last Update Submitted That Met QC Criteria
April 15, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H13-02688
- SOG-13-024 (Other Grant/Funding Number: The Arthritis Society (Canada))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
Emory UniversityVertex Pharmaceuticals IncorporatedNot yet recruitingKnee Osteoarthritis | Knee ArthritisUnited States
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on Progressive walking program with toe-out gait modification
-
Northeastern UniversityRecruitingOsteoarthritis, Knee | Knee Pain ChronicUnited States
-
Riphah International UniversityNot yet recruiting